Technology Times New Jersey
SEE OTHER BRANDS

Reporting on science and technology news in New Jersey

Technology Times New Jersey: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.

Press releases published on June 10, 2025

Township of Lower, NJ Embraces Smarter Procurement with OpenGov

Township of Lower, NJ Embraces Smarter Procurement with OpenGov

TOWNSHIP OF LOWER, NJ, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- With rising bid prices, a limited vendor pool, and a fully paper-based process, the Township of Lower, NJ was ready for a change. Township leaders selected OpenGov, the only …

Thunai.ai Revolutionizes Customer Support with AI Agents

Thunai.ai Revolutionizes Customer Support with AI Agents

BRANCHBURG, NJ, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Thunai.ai announced the launch of an Agentic AI Orchestration platform which is designed to build and deploy agents to automate workflows, enhance engagement, and increase operational …

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …

Otava RF Launches the OTFL1001: An X-Band Digitally Tunable Bandpass Filter Optimized for Advanced RF Systems

Otava RF Launches the OTFL1001: An X-Band Digitally Tunable Bandpass Filter Optimized for Advanced RF Systems

MOORESTOWN, NJ, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Otava RF, a leader in advanced RF solutions, today announced the release of the OTFL1001, an X-Band digitally tunable bandpass filter designed for demanding applications in defense, …

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod RHO data show efgartigimod achieved sustained reduction in autoantibodies and improved functional outcomes in patients …

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus…

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus…

Consideration composed of a $350m up-front payment and up to $1.0bn in development, regulatory and commercial milestones, along with mid-single to low double-digit royalties on Global Net Sales OTELFINGEN, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- …

DPC DATA Acquires Fixed Income Credit Platform BOND DATA, LLC

DPC DATA Acquires Fixed Income Credit Platform BOND DATA, LLC

DPC DATA acquires BOND DATA, LLC to address demand for a scalable, relative-value bond screening and credit surveillance tool for the muni securities market. ROSELAND, NJ, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- DPC DATA (DPCDATA.com) a …

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

NORTH BRUNSWICK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for acute and chronic inflammatory diseases, announces that it will conduct a Phase 2 study of rhu-pGSN …

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced it will …

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

WALTHAM, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the …

Micropolis Holding Company Filed Annual Report on Form 20-F for the Year Ended December 31, 2024

Micropolis Holding Company Filed Annual Report on Form 20-F for the Year Ended December 31, 2024

DUBAI, United Arab Emirates, June 10, 2025 (GLOBE NEWSWIRE) -- Micropolis Holding Company (“Micropolis” or the “Company”) (NYSE American: MCRP), a pioneer in unmanned ground vehicles and AI-driven security solutions, announced today that it has filed its …

CEA Industries to Participate at the Sidoti Conference on June 12, 2025

CEA Industries to Participate at the Sidoti Conference on June 12, 2025

Louisville, Colorado, June 10, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), today announced its participation at the upcoming Sidoti Conference being held virtually June 11-12, 2025. CEA Industries …

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 74 …

Vimeo Elects Adam Cahan, Lydia Jett, and Kirsten Kliphouse to Board of Directors

Vimeo Elects Adam Cahan, Lydia Jett, and Kirsten Kliphouse to Board of Directors

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Vimeo, Inc. (NASDAQ: VMEO), one of the largest and most trusted private video networks in the world, today announced the election of Adam Cahan, Lydia Jett, and Kirsten Kliphouse to its Board of Directors. The …

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, June 10, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 10 juin 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …

Celularity Announces Chief Financial Officer Transition

Celularity Announces Chief Financial Officer Transition

FLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (“CFO”), …

 HP Inc. Declares Dividend

HP Inc. Declares Dividend

PALO ALTO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) has declared a cash dividend of $0.2894 per share on the company’s common stock. The dividend, the fourth in HP’s fiscal year 2025, is payable on October 1, 2025, to stockholders of …

Quick Custom Intelligence Continues Rapid Growth in the Australian Market in Partnership with Gaming Dynamics

Quick Custom Intelligence Continues Rapid Growth in the Australian Market in Partnership with Gaming Dynamics

SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a global leader in operational intelligence software for the gaming and hospitality industries, is pleased to announce continued expansion across Australia in collaboration with …

Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price

Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price

NEW YORK and LEAMINGTON, Ontario, June 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service